FDA Inspection
Bausch Health Companies Inc.Bausch Health Companies Inc. – FDA Inspection, Sep 19, 2019
Record Details
This FDA Inspection record concerns Bausch Health Companies Inc., with an inspection on September 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e2abd951-f3e0-411f-b024-d327f2749e14
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1108379
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bausch Health Companies Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2019 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| February 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch Health Companies Inc.
- FDA Inspection 1229765 - 2024-01-19
- FDA Inspection 1190487 - 2022-09-29
- FDA Inspection 1089615 - 2019-04-26
- FDA Inspection 1007199 - 2017-02-17
- FDA Inspection 914426 - 2015-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.